Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Cancer Vaccines01:30

Cancer Vaccines

985
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
985
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups

29.3K

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.3K
Defenses Against Pathogens and Herbivores02:26

Defenses Against Pathogens and Herbivores

29.5K
Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.
29.5K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.7K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-performance surface plasmon resonance sensor utilizing AuNPs/Au nanocone array for ultrasensitive dopamine detection in complex biological matrices.

Mikrochimica acta·2026
Same author

Synergistic Visible-Light-Driven CO<sub>2</sub> Reduction and H<sub>2</sub>O Oxidation over Ti<sub>3</sub>C<sub>2</sub> Quantum Dot-Modified Cu/g-C<sub>3</sub>N<sub>4</sub> Photocatalysts.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Association between pre-treatment malnutrition and chemotherapy toxicity in patients with advanced or metastatic gastroenteric tumors receiving systemic therapy.

Frontiers in nutrition·2026
Same author

Microfluidic self-assembled polysaccharide@zein-curcumin ternary nanoparticles: Polysaccharide structure, functional properties and stabilization mechanisms.

Food chemistry·2026
Same author

ERBB3 Promotes Malignant Behaviors of Endometrial Cancer Cells with Involvement of the Ras-ERK/MAPK Signaling Pathway.

Cancers·2026
Same author

Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial.

JAMA ophthalmology·2026

Related Experiment Video

Updated: Jan 23, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.8K

Recent Advances in Pathogenic Streptococcus Vaccine Development.

Hongren Wang1, Zhen Qin1, Mingyuan Li1

  • 1Department of Pathogenic Biology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, China.

Current Issues in Molecular Biology
|June 6, 2019
PubMed
Summary

New vaccines against Streptococcus pneumoniae and Streptococcus pyogenes are urgently needed. This review focuses on promising protein-based vaccine candidates currently in clinical development to combat these global health threats.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.1K

Related Experiment Videos

Last Updated: Jan 23, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.8K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.1K

Area of Science:

  • Microbiology
  • Vaccinology
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae (Spn) and Streptococcus pyogenes (Spy) cause significant global morbidity and mortality from invasive and noninvasive diseases.
  • Current Spn vaccines have limitations, and no vaccines are available for Spy, highlighting an urgent need for new interventions.
  • Protein-based vaccine strategies show promise for developing novel Spn and Spy vaccines.

Purpose of the Study:

  • To review the current status of vaccine development for Spn and Spy.
  • To highlight promising protein-based vaccine candidates for these pathogens.
  • To discuss the potential impact of new vaccines on the global infectious disease burden.

Main Methods:

  • Literature review of current Spn and Spy vaccine development.
  • Focus on protein-based vaccine strategies.
  • Analysis of vaccine candidates in clinical trials.

Main Results:

  • Several new Spn and Spy vaccine candidates are under development with promising results.
  • Many of these candidates have advanced to the clinical trial stage.
  • Protein-based approaches are a key focus in current vaccine research.

Conclusions:

  • There is a critical need for improved and novel vaccines against Spn and Spy.
  • Protein-based vaccine strategies offer a promising avenue for future Spn and Spy vaccines.
  • Advancements in vaccine development could significantly reduce the global burden of diseases caused by these bacteria.